36508-71-1
Chemical Structure
Zorubicin hydrochloride
Synonym(s): Rubidazon hydrochloride; Rubidazone hydrochloride
- CAS No.: 36508-71-1
- Formula:C34H36ClN3O10
- Molecular Weight:682.12
InChIKey: NKFHKYQGZDAKMX-PPRKPIOESA-N
SMILES: OC1=C(C(C2=CC=CC(OC)=C2C3=O)=O)C3=C(O)C4=C1C[C@](/C(C)=N/NC(C5=CC=CC=C5)=O)(O)C[C@@H]4O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O)N.Cl
Biological Activity: Zorubicin hydrochloride is an anthracycline Antibiotic. Zorubicin hydrochloride exhibits activity against breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma. Zorubicin hydrochloride shows activity against undifferentiated nasopharyngeal carcinoma either as a monotherapy or in combination with Cisplatin (HY-17394). Zorubicin hydrochloride can be used in research related to breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zorubicin hydrochloride | Zorubicin hydrochloride is an anthracycline Antibiotic. Zorubicin hydrochloride exhibits activity against breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma. Zorubicin hydrochloride shows activity against undifferentiated nasopharyngeal carcinoma either as a monotherapy or in combination with Cisplatin (HY-17394). Zorubicin hydrochloride can be used in research related to breast cancer, leukemia, and undifferentiated nasopharyngeal carcinoma. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Bano N, et al. Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery. ACS omega. 2024 Jun 25;9(25):26762-26779. [Content Brief]
- [2]. Jelić S, et al. Randomized study of zorubicin versus zorubicin-cisplatin in undifferentiated carcinoma of the nasopharynx (UCNT). Annals of oncology : official journal of the European Society for Medical Oncology. 1997 Aug;8(8):739-44. [Content Brief]
Keywords
